PTPMT1 and cancer: Because PTPMT1 is a key regulator of phospholipid biosynthesis, in particular cardiolipin, these data suggest that dysregulated mitochondrial lipid metabolism could be a novel mechanism by which cancer cells can resist therapeutic treatments.